AI in ICUs CLEW offers an FDA-cleared, Class II AI-powered clinical surveillance platform designed to anticipate patient deterioration and support decision-making in critical care areas such as ICUs, ED, PACU, and monitored wards, presenting a compelling value proposition for hospitals seeking to optimize patient outcomes and throughput.

Strategic Partnerships Recent and notable partnerships with AvaSure and Penn State Health indicate CLEW’s traction in expanding virtual surveillance capabilities and virtual ICU deployments, suggesting a market path to scale through system-wide collaborations with large health networks.

Operational ROI The platform’s real-time clinical view facilitates better resource allocation and faster triage, which can translate into reduced length of stay and improved patient throughput, a strong financial argument for hospitals facing capacity constraints.

Tech Stack Fit CLEW’s use of scalable technologies like Apache Flink, Terraform, and modern web/mobile interfaces positions it well for integration with existing hospital IT ecosystems and cloud environments, easing procurement and deployment for IT-heavy healthcare buyers.

Growth signals With a funding history totaling around $21M and a small team size indicative of a focused, high-growth startup, CLEW presents an opportunity to approach health systems prioritizing innovative, AI-backed surveillance to differentiate their care delivery and expand critical care capacity.